5-Bromo-2-(oxetan-3-yloxy)aniline
97%
- Product Code: 155289
CAS:
1599386-56-7
Molecular Weight: | 244.09 g./mol | Molecular Formula: | C₉H₁₀BrNO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective functionalization, making it valuable in constructing complex drug molecules. Commonly employed in medicinal chemistry for building blocks in targeted therapies, especially in oncology and inflammatory disease research. The oxetane ring enhances metabolic stability and solubility, improving drug-like properties in final active pharmaceutical ingredients.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿20,480.00 |
+
-
|
250mg | 10-20 days | ฿34,120.00 |
+
-
|
1g | 10-20 days | ฿83,780.00 |
+
-
|
5-Bromo-2-(oxetan-3-yloxy)aniline
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective functionalization, making it valuable in constructing complex drug molecules. Commonly employed in medicinal chemistry for building blocks in targeted therapies, especially in oncology and inflammatory disease research. The oxetane ring enhances metabolic stability and solubility, improving drug-like properties in final active pharmaceutical ingredients.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :